| Product Code: ETC9692232 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market - Industry Life Cycle |
3.4 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market - Porter's Five Forces |
3.5 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine in Thailand |
4.2.2 Growing awareness about the benefits of pharmacogenomics technology and companion diagnostics |
4.2.3 Supportive government policies and initiatives promoting precision medicine in the healthcare sector |
4.3 Market Restraints |
4.3.1 High costs associated with pharmacogenomics technology and companion diagnostics |
4.3.2 Limited availability of skilled professionals in the field of precision medicine in Thailand |
4.3.3 Regulatory challenges and approval processes for new technologies in the healthcare market |
5 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Trends |
6 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market, By Types |
6.1 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By PCR, 2021- 2031F |
6.1.4 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By In-situ Hybridization, 2021- 2031F |
6.1.5 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.1.6 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.1.7 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.4 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Cardiovascular Disease, 2021- 2031F |
6.2.5 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Immunological Disorders, 2021- 2031F |
6.2.6 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Import-Export Trade Statistics |
7.1 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Export to Major Countries |
7.2 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Imports from Major Countries |
8 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Key Performance Indicators |
8.1 Number of partnerships between healthcare providers and pharmacogenomics technology companies |
8.2 Adoption rate of pharmacogenomics technology and companion diagnostics by healthcare facilities in Thailand |
8.3 Number of research studies and publications on the effectiveness of personalized medicine in the Thai market |
9 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market - Opportunity Assessment |
9.1 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market - Competitive Landscape |
10.1 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Thailand Pharmacogenomics Technology Theranostics Companion Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here